Due to the aggressive nature of osteosarcoma metastatic to the lung, an aggressive form of rare pediatric bone cancer that requires resections to sequentially remove tumors from the lung given the ...

The Company positive data in its Phase 2b clinical trial of OST-HER2 in recurrent, fully resected, lung metastatic osteosarcoma demonstrating statistically significant benefit in the 12-month ...